Abiomed Inc (ABMD)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Michael R. Minogue
Employees:
2,000
22 CHERRY HILL DR, DANVERS, MA 01923
9787775410

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors. It sells its products through direct sales and clinical support personnel in the United States, Japan, Europe, Canada, Latin America, and the Asia-Pacific.

Data derived from most recent annual or quarterly report
Market Cap 17.181 Billion Shares Outstanding45.091 Million Avg 30-day Volume 2.174 Million
P/E Ratio42.0948 Dividend Yield0.0 EPS2.34
Price to Revenue10.4547 Debt to Equity0.0 EBITDA370.93 Million
Price to Book Value7.2928 Operating Margin23.6118 Enterprise Value10.292 Billion
Current Ratio7.928 EPS Growth0.797 Quick Ratio6.824
1 Yr BETA 1.2194 52-week High/Low 381.99 / 219.85 Profit Margin24.8361
Operating Cash Flow Growth-10.8538 Free Cash Flow to Firm (FCFF) TTM 118.787 Million Free Cash Flow to Equity (FCFE) TTM164.545 Million
Altman Z-Score45.8634
View SEC Filings from ABMD instead.

View recent insider trading info

Abiomed Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ABMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ABMD

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-12-27 by MINOGUE MICHAEL R
  • 4: filed on 2022-12-27 by GREENFIELD ANDREW J
  • 4: filed on 2022-12-27 by BEGAN MARC A
  • 4: filed on 2022-12-27 by JOHNSON PAULA A
  • 4: filed on 2022-12-27 by RIVET JEANNINE M
  • 4: filed on 2022-12-27 by THOMAS PAUL
  • 4: filed on 2022-12-27 by ROLLE MYRON L
  • 4: filed on 2022-12-27 by VAN GORDER CHRIS
  • 4: filed on 2022-12-20 by GREENFIELD ANDREW J
  • 4: filed on 2022-12-20 by MINOGUE MICHAEL R

    • Events (8k)

  • 8-K: filed on 2022-12-22:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-01:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-12:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-21:
    Item 8.01: Other Events
  • 8-K: filed on 2022-04-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-01:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-10-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-13:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SUTTER MARTIN P

    • Director
    		 0 2022-12-22 2

    RIVET JEANNINE M

    • Director
    		 0 2022-12-22 1

    THOMAS PAUL

    • Director
    		 0 2022-12-22 2

    PUHY DOROTHY E

    • Director
    		 0 2022-12-22 1

    MINOGUE MICHAEL R CHAIRMAN, PRESIDENT, CEO

    • Officer
    • Director
    		 0 2022-12-22 3

    JOHNSON PAULA A

    • Director
    		 0 2022-12-22 1

    GREENFIELD ANDREW J VP, CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2022-12-22 3

    TRAPP TODD A VICE PRESIDENT, CFO

    • Officer
    		 0 2022-12-22 3

    VAN GORDER CHRIS

    • Director
    		 0 2022-12-22 1

    BEGAN MARC A VP & GENERAL COUNSEL

    • Officer
    		 0 2022-12-22 2

    ROLLE MYRON L

    • Director
    		 0 2022-12-22 1

    PLANO MATTHEW T. VP, GLOBAL OPERATIONS

    • Officer
    		 0 2022-12-22 2

    ROSE ERIC A MD

    • Director
    		 15,203 2022-08-10 0

    WEBER DAVID M CHIEF OPERATING OFFICER

    • Officer
    		 131,811 2022-03-31 0

    HOWLEY MICHAEL G VP, GLOBAL SALES & MARKETING

    • Officer
    		 51,365 2020-05-29 0

    BOLT WILLIAM J SVP, QA AND REGULATORY AFFAIRS

    • Officer
    		 61,381 2019-05-24 0

    MCLEOD IAN VP, CORPORATE CONTROLLER

    • Officer
    		 7,079 2018-02-28 0

    TOMSICEK MICHAEL JOHN VICE PRESIDENT, CFO

    • Officer
    		 27,081 2017-07-15 0

    TERMEER HENRI A

    • Director
    		 345,533 2016-08-09 0

    AUSTEN W GERALD

    • Director
    		 87,241 2015-08-12 0

    BOWEN ROBERT CHIEF FINANCIAL OFFICER

    • Officer
    		 76,265 2015-05-15 0

    LATAIF LOUIS E

    • Director
    		 111,175 2015-04-29 0

    O CONNELL DESMOND JR

    • Director
    		 67,062 2011-04-01 0

    DOLLENS RONALD W

    • Director
    		 5,839 2010-08-11 0

    ABIOMED INC

    • Director
    		 2,731,667 2008-12-16 0

    SUTHERBY DANIEL J CFO, CAO

    • Officer
    		 43,354 2008-09-16 0

    FITCH PATRICIA A. VICE PRESIDENT OF SALES

    • Officer
    		 5,000 2008-05-23 0

    KUNG ROBERT T V SVP, CHIEF SCIENTIFIC OFFICER

    • Officer
    		 418,228 2007-05-30 0

    MACDONALD CHRISTOPHER D SVP GLOBAL SALES

    • Officer
    		 167,546 2007-05-30 0

    BENALI KARIM CHIEF MEDICAL OFFICER

    • Officer
    		 170,989 2007-05-30 0

    FARRA ROBERT VP ENGINEERING & MANUFACTURING

    • Officer
    		 71,141 2007-05-30 0

    MCEVOY STEPHEN C VP AND GENERAL COUNSEL

    • Officer
    		 0 2007-05-03 0

    JIMENEZ JAVIER VP GM ABIOMED EUROPE

    • Officer
    		 135,628 2006-09-30 0

    FLAHERTY SHEILA MARIE VP, GENERAL COUNSEL

    • Officer
    		 85,547 2006-09-30 0

    OBRIEN JOHN F

    • Director
    		 335,804 2006-05-11 0

    GOTTLIEB DAVID

    • Director
    		 35,731 2006-03-31 0

    STICKEL GARY VP OF HR

    • Officer
    		 57,853 2006-03-31 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ABIOMED INC ABMD 2022-12-22 22:15:03 UTC 3.8421 0.4779 45000
    ABIOMED INC ABMD 2022-12-22 21:45:03 UTC 3.8421 0.4779 45000
    ABIOMED INC ABMD 2022-12-22 21:15:03 UTC 3.8421 0.4779 45000
    ABIOMED INC ABMD 2022-12-22 20:45:03 UTC 3.8421 0.4779 45000
    ABIOMED INC ABMD 2022-12-22 20:15:04 UTC 3.8421 0.4779 45000
    ABIOMED INC ABMD 2022-12-22 19:45:04 UTC 3.8421 0.4779 45000
    ABIOMED INC ABMD 2022-12-22 19:15:04 UTC 3.8421 0.4779 45000
    ABIOMED INC ABMD 2022-12-22 18:45:03 UTC 3.8745 0.4455 100000
    ABIOMED INC ABMD 2022-12-22 18:15:03 UTC 3.8745 0.4455 100000
    ABIOMED INC ABMD 2022-12-22 17:45:04 UTC 3.8745 0.4455 100000
    ABIOMED INC ABMD 2022-12-22 17:15:03 UTC 3.8745 0.4455 100000
    ABIOMED INC ABMD 2022-12-22 16:45:03 UTC 3.8844 0.4356 100000
    ABIOMED INC ABMD 2022-12-22 16:15:03 UTC 3.8844 0.4356 100000
    ABIOMED INC ABMD 2022-12-22 15:45:03 UTC 3.8844 0.4356 100000
    ABIOMED INC ABMD 2022-12-22 15:15:04 UTC 3.8844 0.4356 100000
    ABIOMED INC ABMD 2022-12-22 14:45:04 UTC 3.8844 0.4356 100000
    ABIOMED INC ABMD 2022-12-22 14:15:03 UTC 3.8844 0.4356 100000
    ABIOMED INC ABMD 2022-12-22 13:45:03 UTC 3.9418 0.3782 100000
    ABIOMED INC ABMD 2022-12-22 13:15:03 UTC 3.9418 0.3782 100000
    ABIOMED INC ABMD 2022-12-22 12:45:03 UTC 3.9418 0.3782 60000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    AGF Investments Trust- AGFIQ U.S. Market Neutral Value Fund ABMD -10.0 shares, $-2770.6 2020-09-30 N-PORT
    FundVantage Trust- Gotham Absolute 500 Core Fund ABMD -12.0 shares, $-1741.92 2020-03-31 N-PORT
    FundVantage Trust- Gotham Neutral 500 Fund ABMD -18.0 shares, $-5737.14 2021-03-31 N-PORT
    INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund ABMD -192.0 shares, $-61196.16 2021-03-31 N-PORT
    Nuveen Investment Trust- Nuveen Equity Market Neutral Fund ABMD -650.0 shares, $-184977.0 2021-05-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments